New guideline recommendations on iron deficiency could improve quality of life for people with heart failure

News & Events

29 June 2022
AUTHOR: HFPN Admin

Following updates to recommendations around iron deficiency in the 2021 European Society of Cardiology (ESC) heart failure guidelines, the HFPN has updated its Spotlight on iron deficiency report, originally published in 2020.

The updated European guidelines recommend that all people with heart failure be screened for iron deficiency, and provided new treatment recommendations. Yet despite clear guidance that could improve outcomes for people living with heart failure, challenges to implementation remain. The report discusses common barriers and how these may be overcome.

Iron deficiency can increase the risk of hospitalisation and mortality among people living with heart failure and can drastically impact quality of life by exacerbating symptoms such as fatigue and breathlessness. However, partly due to lack of awareness, iron deficiency often goes undiagnosed and untreated.

The report makes five key recommendations:

 
Read the full report

 

Tagged:

More from News & Events

New manifesto calls for heart failure to be included in EU c
New manifesto calls for heart failure to be included in EU c...
29 September 2026
On World Heart Day, HFPN launches a new manifesto calling on European policymakers to make sure heart failure is fully integrated into the forthcoming European Union (EU) Council R...
Read article
New research sets out how to strengthen specialist heart fai
New research sets out how to strengthen specialist heart fai...
22 September 2026
The European Journal of Cardiovascular Nursing has published new research by the HFPN identifying urgent policy actions to strengthen specialist heart failure (HF) nursing in Europ...
Read article
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca, Bayer and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership. EU Transparency Register ID: 223430420230-66.